Insight into male menopause'
|
|
- Branden Blair
- 6 years ago
- Views:
Transcription
1 Insight into male menopause' Dr Mark Vanderpump MD FRCP Consultant Endocrinologist Clinics: Tuesday PM
2 Mark Vanderpump Consultant Physician and Endocrinologist
3 Introduction Serum total and free testosterone decrease with age Decline known as andropause or late-onset hypogonadism Complete oestrogen deficiency syndrome known in women Decline in testosterone in ageing men is modest and possible clinical consequences not been well-established. Changes in body function in ageing men similar to manifestations of hypogonadism Does decline in testosterone with ageing cause these changes? Prescriptions for testosterone preparations increased by 90% to 300,000 dispensed items annually over 10 years NHS costs 267% rose from 3 2 to 11 7 million/year
4 Objectives Testosterone levels in the ageing man Which tests to do and when Diagnosis of hypogonadism in the ageing man Who should be treated? How should you treat?
5
6
7 Cases Case 1 59 year old married CEO c/o loss of libido, poor erections, hot flushes Hypertension on Amlodipine. On statin. HbA1c 43mmol/mol BMI 31Kg/m 2, waist circumference 42 inches Checked testosterone level at BUPA medical 9.9nmol/L Convinced that has menopause and requests Testosterone Case 2 62 year old teacher c/o low energy, myalgia post exercise, difficulty with memory. PMH Crohn s disease on Azathioprine BMI 26Kg/m2, waist circumference 36 inches Recent fracture elbow post fall, BMD T score osteopaenic range Recommended to have testosterone checked by orthopaedic surgeon Testosterone 7.8nmol/L
8 Physiology
9 Measurement of testosterone What form (total or free), when during the day, and how often should serum testosterone be measured? Obesity decreases total testosterone concentration usually without lowering the free testosterone concentration Severe obesity (BMI >40kg/m 2 ) may cause hypothalamic hypogonadism as well as the binding abnormality Equilibrium dialysis (not analogue method) will distinguish a binding abnormality and hypogonadism in an obese male Free testosterone concentration from total testosterone, SHBG, and albumin concentrations, may also be reliable Harmonised reference range of total testosterone in 9000 non-obese European/US men is nmol/L
10 Evaluation of possible hypogonadism
11 Relationship between age and hormones
12 Diurnal rhythm of testosterone secretion
13 Relationship between hormones and BMI
14 Serum testosterone levels in obesity
15 Lowered testosterone levels in obesity
16 Consequences of testosterone decline Sexual function: In 3369 men ages years (European Male Aging Study) only symptoms significantly associated with serum testosterone <11.1nmol/L were three sexual symptoms (poor morning erection, low sexual desire, and erectile dysfunction) Bone mineral density and fractures: In men >65 years, the risk of non-vertebral fractures was increased in those with low bioavailable oestradiol and testosterone and high SHBG. Muscle and fat mass: Hypogonadal men have less muscle mass and more fat mass than normal men; testosterone treatment tends to reverse these changes
17 Consequences of testosterone decline Anaemia: In placebo-controlled trials in older men, testosterone treatment results in increase in haemoglobin when compared with placebo, but correction of anaemia not been demonstrated Mood: Associated with depressive symptoms, even after correction for possible confounders. In hypogonadal men, raising testosterone concentration improved mood Cognitive function: Decline in neuropsychological function Metabolic cardiovascular parameters: Associated with development of central obesity, higher insulin concentrations, the metabolic syndrome, type 2 diabetes, high CRP and increased mortality
18 Does late-onset hypogonadism exist? European Male Aging Study (EMAS) described 3369 men aged with low testosterone for no reason other than age Low testosterone (<11nmol/L) and three sexual symptoms (in 2.1% of men) significantly associated with lower Hb, heel BMD, mid-upper arm circumference, and physical performance More severe hypogonadism (serum testosterone concentration <8nmol/L) was also associated with insulin resistance Associations were stronger when serum testosterone concentration was <8nmol/L than when 8-11nmol/L range These data support the concept of low testosterone syndrome in small % of middle aged and older men
19 Clinical trial data Testosterone for three years did not increase BMD in spine or hip compared with placebo, but secondary analysis showed that the lower the pre-treatment testosterone, the greater the testosterone treatment effect on spine BMD Testosterone for 1 year did not increase spine BMD compared with placebo but prevented a decrease in hip BMD Study in which testosterone raised to higher than mid-normal treatment significantly increased BMD 10% spine and 2.5% hip Meta-analysis of 8 trials of 365 patients concluded that trials of im testosterone esters showed a modest improvement in spine (but not femoral neck) BMD, but not transdermal testosterone
20 Clinical trial data Body composition: Increase in lean body mass (2.7 kg) and a greater reduction in fat mass (-2.0 kg) than placebo Muscle strength: Increase in lean mass not accompanied by increases in muscle strength Physical function: No improvement in various parameters of physical function in two trials, but in the third was associated with increase in composite physical performance test Quality of life: In meta-analysis of 17 trials, those that enrolled subjects with low testosterone showed a large effect on libido, but little or no effect on erectile function and sexual satisfaction Mood: Two small RCTs showed benefit on mood
21 Men > 65 years (n = 790). Low serum testosterone <9.54nmol/L on two occasions Symptoms and objective evidence of sexual dysfunction, physical dysfunction, and reduced vitality were randomly assigned to receive testosterone or placebo gel for one year and participated in three main trials (the Sexual Function, Physical Function, and Vitality trials). Over 51,000 men screened to enroll the 790 men who met inclusion criteria (only 1.5% of those screened had low serum testosterone and hypogonadal symptoms). After 1 year of testosterone gel therapy, serum testosterone concentrations increased into the mid-normal range for men ages years
22 The Testosterone Trials (NEJM 2016) Increases in sexual activity and desire, and erectile function No significant difference in walking distance on six-minute walk test in the Physical Function trial (but differences were seen when subjects from all three trials were included) No significant benefit on vitality, however, men receiving testosterone reported better mood and lower severity of depressive symptoms when compared with placebo Rates of adverse events similar with testosterone and placebo The risk of cardiovascular complications could not be assessed given the size and duration of the trial
23 Potential harmful effects Prostate cancer: Meta-analysis of 51 randomised trials no increased incidence, need for prostate biopsy, or other prostate outcomes Benign prostatic hyperplasia: No effect on lower urinary tract symptoms or other prostate outcomes Sleep apnoea: Physiological replacement increases sleep apnoea but meta-analysis showed no difference Erythrocytosis: In study of 45 men (age 72 years) im testosterone increased haematocrit to >52% in 24%. In Framingham men in highest quintile haematocrit had greater overall mortality and cardiovascular mortality Serum lipids: No effect
24 Potential harmful effects FDA issued alerts re potential concerns about testosterone therapy and cardiovascular safety Despite conflicting and inconclusive evidence, there is possibility of increased cardiovascular risk (MI and CVA) Retrospective studies limited by inability to verify diagnoses, indications for testosterone therapy, testosterone dose, and information on serum testosterone concentrations immediately before initiating therapy and during therapy IM preparations associated with a greater risk of MI and stroke but not VTE when compared with testosterone gel
25 Testosterone treatment Testosterone metabolised so rapidly by liver that impossible to maintain normal serum testosterone with oral testosterone Testosterone gels typically result in normal and relatively stable serum testosterone concentrations Other factors affect choice of regimen, including patient preference, cost, convenience Gels cost the most, the patch costs somewhat less, and injectable esters cost the least. Testosterone undecanoate (Nebido) as 1g deep IM injection, with a second dose six weeks after the first and subsequent doses every weeks
26 NHS advice
27 What do I do? Measure fasting total testosterone x2 Repeat with SHBG, LH, FSH and Prolactin Assess free testosterone level with SHBG FT4, TSH, Cortisol, MRI pituitary, Ferritin Look for other clinical features of insulin resistance Bone density useful at baseline Check baseline FBC, PSA Offer Testosterone gel trial for 3 months Symptom improvement 3 months, BMD 2 years Switch to Nebido if preferred as long-term treatment Six monthly check of FBC/PSA Agree definition of successful clinical outcome
28 Conclusion Late-onset hypogonadism occurs in 2% ageing males Level that considered unequivocally low are <7nmol/L Confirmed if <7-9nmol/L x2 early am with estimation of free testosterone with SHBG and pituitary pathology excluded Sexual symptoms are loss of libido and erectile dysfunction Offer replacement therapy to those with testosterone deficiency symptoms and testosterone (<7-9nmol/L) Individualised evaluation of co-morbidities and risk-benefit Safety profile appears good but evidence from large randomised prospective trials of beneficial effects and cardiovascular safety of testosterone therapy needed
29 Thank you! How to refer? Call
Issues. What is a low testosterone? Who needs testosterone therapy? Benefits/adverse effects of testosterone replacement Treatment options
Male Hypogonadism Jauch Symposium Waterloo, IA May 17, 2013 Janet A. Schlechte, M.D. Disclosure of Financial Relationships Janet A. Schlechte, M.D. has no relationships with any proprietary entity producing
More informationMI Androgen Deficiency Hypogonadism
MI Androgen Deficiency Hypogonadism WADA TUE Expert Group John A Lombardo, MD October 2014, Columbus, Ohio USA Hypothalamic-Pituitary-Gonadal Axis / 2 Hypogonadism/Androgen Deficiency Clinical syndrome:
More informationDonald W. Morrish, MD, PhD, FRCPC Presented at Mountain Man: Men's Health Conference, May Terry s Testosterone
Focus on CME at University of Alberta ADAM: Dealing with the Decline Donald W. Morrish, MD, PhD, FRCPC Presented at Mountain Man: Men's Health Conference, May 2005 We now know there is a decline in total
More informationAssociate Professor Geoff Braatvedt
Associate Professor Geoff Braatvedt Endocrinologist Diabetologist and Physician Green Lane and Auckland City Hospitals Auckland 14:00-14:55 WS #145: Approach to Low Testosterone Values 15:05-16:00 WS #157:
More informationSecrets of Abang Sado : Effects of testosterone therapy. Azraai Nasruddin
+ Secrets of Abang Sado : Effects of testosterone therapy Azraai Nasruddin + Testosterone Testosterone : Steroid hormone - Made primarily by the testicles in males - Small amounts produced by the adrenal
More informationNatural Hair Transplant Medical Center, Inc Dove Street, Suite #250, Newport Beach, CA Phone
Natural Hair Transplant Medical Center, Inc. 1000 Dove Street, Suite #250, Newport Beach, CA 92660 Phone-949-622-6969 Finasteride (PROPECIA ) Acknowledgement Finasteride is an oral medication, manufactured
More informationJeremiah Murphy, MD Mercy Urology Clinic. October 21, 2017
Jeremiah Murphy, MD Mercy Urology Clinic October 21, 2017 Describe an appropriate strategy for the evaluation and diagnosis of male hypogonadism Endocrine Society Clinical Practice Guideline-2010 Review
More informationUnitedHealthcare Pharmacy Clinical Pharmacy Programs
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 2018-9 Program Prior Authorization/Medical Necessity Topical Androgens Medication Axiron*, Androderm, Androgel*, Fortesta*, Natesto*,
More informationTestosterone Hormone Replacement Drug Class Prior Authorization Protocol
Testosterone Hormone Replacement Drug Class Prior Authorization Protocol Line of Business: Medicaid P&T Approval Date: February 21, 2018 Effective date: April 1, 2018 This policy has been developed through
More informationTestosterone Hormone Replacement Drug Class Prior Authorization Protocol
Line of business: Medi-Cal Effective Date: August 16, 2017 Revision Date: August 16, 2017 Testosterone Hormone Replacement Drug Class Prior Authorization Protocol This policy has been developed through
More informationDrug Class Monograph
Drug Class Monograph Class: Testosterone Hormone Replacement Drug: Androderm (testosterone transdermal system), Androgel (testosterone topical gel), Axiron (testosterone topical solution), Aveed (testosterone
More informationAndrogens and Anabolic Steroids Prior Authorization with Quantity Limit - Through Preferred Topical Androgen Agent
Androgens and Anabolic Steroids Prior Authorization with Quantity Limit - Through Preferred Topical Androgen Agent Androgens/Anabolic Steroids Prior Authorization with Quantity Limit Through Preferred
More informationOriginal Research Declining testicular function in aging men
(2003) 15, Suppl 4, S3 S8 & 2003 Nature Publishing Group All rights reserved 0955-9930/03 $25.00 www.nature.com/ijir Original Research 1 * 1 Wesley Woods Health Center, Atlanta, Georgia, USA Age-related
More informationTestosterone Effects in Transmen
Transmen Testosterone Effects in Transmen EFFECT Skin oiliness/acne Facial/body hair growth Scalp hair loss Increased muscle mass/strength Fat redistribution Cessation of menses Clitoral enlargement Vaginal
More informationMedical Policy Testosterone Therapy
Medical Policy Testosterone Therapy Subject: Testosterone Therapy Effective Date: April 2015 Overview: Testosterone cypionate, testosterone enanthate, testosterone undecanoate, and testosterone pellet
More informationTREATMENT OPTIONS FOR MALE HYPOGONADISM
TREATMENT OPTIONS FOR MALE HYPOGONADISM Bruce Biundo, RPh, FACA PCCA Pharmacy Consulting Department Updated July 2012 Hypogonadism in men is primarily a state involving lower than expected levels of testosterone,
More informationTESTOFEN HUMAN CLINICAL TRIAL GENCOR PACIFIC, INC. Copyright 2006 by Gencor Pacific, Inc.
GENCOR PACIFIC, INC. 920 E. Orangethorpe Avenue, Suite B, Anaheim, CA 92801 Ph: 714.870.8723 714.870.8724 efax: 732.875.0306 drjit@gencorpacific.com gita@gencorpacific.com www.gencorpacific.com TESTOFEN
More informationPRODUCT INFORMATION TESTOVIRON DEPOT. (testosterone enanthate)
PRODUCT INFORMATION TESTOVIRON DEPOT (testosterone enanthate) NAME OF THE MEDICINE Testosterone enanthate is designated chemically as 17 beta-heptanoyloxy-4-androstene-3- one. The empirical formula of
More informationHARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES
Generic Brand HICL GCN Exception/Other METHYL ANDROID METHITEST METHYL TESTRED 01404 ROUTE MISCELL. CYPIONATE ENANTHATE GUIDELINES FOR USE ANDRODERM ANDROGEL AXIRON FORTESTA NATESTO STRIANT TESTIM VOGELXO
More informationFINASTERIDE (PROPECIA, PROSCAR) SIDE EFFECT & CONSENT FORM
750 West Broadway Street Suite 905 Vancouver, BC M5Z 1K1 FAX: (604) 648-9003 vancouveroffice@donovanmedical.com FINASTERIDE (PROPECIA, PROSCAR) SIDE EFFECT & CONSENT FORM What is finasteride? Finasteride
More informationPrescribing Guidelines
guidance for use by Prescribers in Primary Care that choose to prescribe. This is not a mandatory document Version 13 15-06-18 Barnsley, Rotherham & Sheffield Clinical Commissioning Groups Prescribing
More informationRisks and benefits of testosterone therapy in older men. Matthew Spitzer, Grace Huang, Shehzad Basaria, Thomas G. Travison and Shalender Bhasin
Risks and benefits of testosterone therapy in older men Matthew Spitzer, Grace Huang, Shehzad Basaria, Thomas G. Travison and Shalender Bhasin Abstract In young men (defined as age
More informationSeptember 17, FDA background documents for the discussion of two major issues in testosterone replacement therapy (TRT):
JOINT MEETING FOR BONE, REPRODUCTIVE AND UROLOGIC DRUGS ADVISORY COMMITTEE (BRUDAC) AND THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE (DSARM AC) September 17, 2014 FDA background documents for
More information1001 West Broadway, Vancouver, BC V6H 4B1. Topical Finasteride
1001 West Broadway, Vancouver, BC V6H 4B1 Topical Finasteride 1 Topical finasteride is a solution containing the drug finasteride typically sold under the brand names Propecia and Proscar. The Finasteride
More informationThe ICL Insider. Lab Testing: Testosterone. In This Issue. The Debate
The ICL Insider February 2017 Volume 2, Issue 2 Lab Testing: Testosterone In This Issue Testosterone shashtilak@iclabs.ca Next Issue: Expected Release April 2017 The Debate Aging is accompanied by various
More informationThe Testosterone Quandary. Beth Crowder, PhD, APRN
The Testosterone Quandary Beth Crowder, PhD, APRN Objectives Define testosterone, the hypothalamic-pituitary-gonadotrophic axis, and normal blood levels List functions of testosterone and symptoms of low
More informationM0BCore Safety Profile. Pharmaceutical form(s)/strength: 5 mg SE/H/PSUR/0002/006 Date of FAR:
M0BCore Safety Profile Active substance: Finasteride Pharmaceutical form(s)/strength: 5 mg P-RMS: SE/H/PSUR/0002/006 Date of FAR: 16.05.2014 4.3 Contraindications Finasteride is not indicated for use in
More informationChapter 5. General discussion
Chapter 5. General discussion 127 Chapter 5 In 2003, two review papers concluded that endogenous androgens do not show any consistent association with cardiovascular disease (CVD) risk 1,2. Apparently,
More informationAndrogenes and Antiandrogenes
Androgenes and Antiandrogenes Androgens The androgens are a group of steroids that have anabolic and/or masculinizing effects in both males and females. Testosterone [tess-toss-terone], the most important
More informationThe Science of. NUTRICULA Longevity Journal
32 December, 2011 The Science of 33 NUTRICULA Longevity Journal As men age, there is often a decline in libido and sexual function. This decline frequently interferes in intimacy within romantic relationships,
More informationPRODUCT INFORMATION PRIMOTESTON DEPOT. (testosterone enantate)
PRODUCT INFORMATION PRIMOTESTON DEPOT (testosterone enantate) NAME OF THE MEDICINE Testosterone enantate is designated chemically as 17 beta-heptanoyloxy-4-androstene-3- one. The empirical formula of testosterone
More informationNatural testosterone enhancement
Search Search pages & people Search Search Search pages & people Search Natural testosterone enhancement Buy Herbal T Natural Testosterone Booster: Increase Energy, Endurance, and Libido. Male Enhancement
More informationPRODUCT INFORMATION. Testosterone Phenylpropionate: Testosterone Phenylpropionate is 3-oxoandrost-4-en-17β-yl
PRODUCT INFORMATION SUSTANON '250' NAME OF THE MEDICINE Sustanon '250' ('250' mg/ml for injection): testosterone propionate, testosterone phenylpropionate, testosterone isocaproate, testosterone decanoate.
More informationAdverse effects of anabolic androgenic steroids abuse on gonadal function, glucose homeostasis and cardiovascular function
Adverse effects of anabolic androgenic steroids abuse on gonadal function, glucose homeostasis and cardiovascular function Associate Professor Caroline Kistorp, Ph.D Department of Internal Medicine, Herlev
More informationAffirming Care of the Transgender Patient
Mountain West AIDS Education and Training Center Affirming Care of the Transgender Patient Jessica Rongitsch, MD, FACP This presentation is intended for educational use only, and does not in any way constitute
More informationPRODUCT INFORMATION PROVIRON
PRODUCT INFORMATION PROVIRON NAME OF TE MEDICINE Mesterolone is a white to yellowish crystalline powder and is practically insoluble in water. The chemical name for mesterolone is 17 beta-ydroxy-1 alpha-methyl-5
More informationMonth/Year of Review: September 2013 Date of Last Review: December 2009
Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119 Copyright 2013 Oregon State University. All Rights
More informationElements for a public summary
VI.2 VI.2.1 Elements for a public summary Overview of disease epidemiology Prostate gland enlargement is a common condition as men get older. Also called benign prostatic hyperplasia (BPH) and prostatic
More informationPackage Leaflet: Information for the patient. Sustanon 250, 250 mg/ml, solution for injection (testosterone esters)
Package Leaflet: Information for the patient Sustanon 250, 250 mg/ml, solution for injection (testosterone esters) Read all of this leaflet carefully before you start using this medicine because it contains
More informationHGH for Sale Natural Anti-Aging Human Growth Hormone
HGH for Sale Natural Anti-Aging Human Growth Hormone Human growth hormone is one of the hottest supplement trends on the market, and now you can purchase top-quality HGH to be delivered right to your home!
More informationRobert Perlstein, M.D. Medical Officer. Center for Drug Evaluation and Research. U.S. Food & Drug Administration
-------------------- Robert Perlstein, M.D. Medical Officer Center for Drug Evaluation and Research U.S. Food & Drug Administration -------------------- Sentencing of Food and Drug Offenses Before the
More informationClinical Study Synopsis
Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace
More informationXYOSTED (testosterone enanthate) injection, for subcutaneous use CIII Initial US approval: 1953 IMPORTANT SAFETY INFORMATION
ANTARES PHARMA ANNOUNCES THE COMMERCIAL AVAILABILITY OF XYOSTED (TESTOSTERONE ENANTHATE) INJECTION A NEW TREATMENT FOR ADULT MEN DIAGNOSED WITH TESTOSTERONE DEFICIENCY XYOSTED - A Novel Subcutaneous Testosterone
More informationClinical Policy: Testosterone Reference Number: AZ.CP.PHAR.02 Effective Date: Last Review Date: Line of Business: Arizona Medicaid
Clinical Policy: Reference Number: AZ.CP.PHAR.02 Effective Date: 11.16.16 Last Review Date: 09.12.18 Line of Business: Arizona Medicaid Revision Log See Important Reminder at the end of this policy for
More informationElements for a Public Summary. Overview of disease epidemiology
VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Benign prostatic hyperplasia (BPH) (an increase in size of the prostate that is not cancerous) is the most prevalent of all diseases
More informationFINCAR Tablets (Finasteride)
Published on: 10 Jul 2014 FINCAR Tablets (Finasteride) Composition FINCAR Tablets Each film-coated tablet contains: Finasteride USP - 5 mg Dosage Form Tablet Pharmacology Pharmacodynamics Mechanism of
More informationMedication Policy Manual
Independent licensees of the Blue Cross and Blue Shield Association Medication Policy Manual Topic: Non-preferred, non-transdermal testosterone replacement therapy products (Android, Aveed, Androxy, Methitest,
More informationCurrent Data and Considerations Novel Testosterone Formulations
Current Data and Considerations Novel Testosterone Formulations 1 Current and Novel Therapeutic Options Module 4 2 Objectives Identify desirable characteristics of ideal testosterone formulations Review
More information2. Testosterone and Aging
2. Testosterone and Aging Shalender Bhasin, MD Thomas G. Travison, PhD Ravi Jasuja, PhD Carlo Serra, PhD Thomas W. Storer, PhD Shehzad Basaria, MD Case 2-1 A 78-year-old man requests evaluation for weakness,
More informationTestosterone Use and Effects
Parkland College Natural Sciences Poster Sessions Student Works 2013 Testosterone Use and Effects Brandon Mills Parkland College Recommended Citation Mills, Brandon, "Testosterone Use and Effects" (2013).
More informationSELECT WHEY SOME THOUGHTS ON WHY WHEY PROTEIN CONTINUES TO BE CLINICALLY IMPORTANT
SELECT WHEY SOME THOUGHTS ON WHY WHEY PROTEIN CONTINUES TO BE CLINICALLY IMPORTANT Certainly, a legitimate concern about whey protein supplementation is allergenicity. However, while this concern is warranted,
More information4.2 Posology, method and duration of administration
The format of this leaflet was determined by the Ministry of Health and its content was checked and approved by it in May 2011. 1. NAME OF MEDICINAL PRODUCT Testoviron Depot Oily solution for injection
More informationIcd-10 low levels of testosterone
Icd-10 low levels of testosterone The Borg System is 100 % Icd-10 low levels of testosterone 1-10-2017 if your hormone levels are too high or too low, you may have a hormone disorder. Hormone diseases
More informationMonitoring Hormone Therapy Mark Newman, M.S. President of Precision Analytical Inc.
Mr Mark Newman Monitoring Hormone Therapy Mark Newman, M.S. President of Precision Analytical Inc. 2 Avoiding Pitfalls in (B)HRT Monitoring and Picking the Right Lab Test Objectives: Outline how expected
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Reference Number: CP.CPA.291 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Commercial Revision Log See Important Reminder at the end of this policy for important regulatory
More informationSUMMARY and OBJECTIVES. LOW T- I m half the man I used to be. Prevalence of Low-T. Definition of Hypogonadism 9/19/ Million men in the US
SUMMARY and OBJECTIVES LOW T- I m half the man I used to be A discussion of male hypogonadism David Doriguzzi, PA-C Valley Endocrine & Diabetes Consultants Definition Prevalence Causes Signs & Symptoms
More informationMale Hormone Replacement Therapy. Punita Dhindsa D.O PGY 2
Male Hormone Replacement Therapy Punita Dhindsa D.O PGY 2 Physiology of Testosterone & Causes of Hypogonadism in Males The use of testosterone therapy is very common in the US, with an estimated 2.3 million
More informationA mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 men
European Journal of Endocrinology (2004) 151 241 249 ISSN 0804-4643 EXPERIMENTAL STUDY A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 men Paul
More informationTestosterone Topical/Buccal/Nasal
BENEFIT APPLICATION Testosterone Topical/Buccal/Nasal DRUG POLICY Benefit determinations are based on the applicable contract language in effect at the time the services were rendered. Exclusions, limitations
More informationMens Health Post Puberty. Nayan Patel PharmD
Mens Health Post Puberty Nayan Patel PharmD Definition of Androgen Deficiency * Consistently low testosterone * Associated signs/symptoms * Evidence based review of literature * Data is weak at best Definition
More informationPHYSICIANS CIRCULAR FINASTERIDE PROSCAR. Tablet 5-Alpha Reductase Inhibitor
PHYSICIANS CIRCULAR FINASTERIDE PROSCAR Tablet 5-Alpha Reductase Inhibitor FINASTERIDE (PROSCAR) a synthetic 4-azasteroid compound, is a specific inhibitor of Type II 5α-reductase, an intracellular enzyme
More informationHormone management of trans men
Blog Managing trans people within a health service Join the discussion: www./blog Hormone management of trans men Jonny Coxon, GP and Clinical Assistant, Endocrinology; Leighton Seal, Consultant Endocrinologist,
More informationTransgender 201: Case Discussion Group
Transgender 201: Case Discussion Group Melissa Davis, MD Maria Barnett, DO October 19, 2017 Maria Barnett, DO, Date Welcome! Disclosures Introductions Discussion The total time of this workshop will depend
More informationAlthough women produce only
For mass reproduction, content licensing and permissions contact Dowden Health Media. Mary Lake Polan, MD, PhD, MPH Katharine Dexter McCormick and Stanley McCormick Memorial Professor and Chair Emeritus,
More informationGynaecomastia. Benign breast conditions information provided by Breast Cancer Care
Gynaecomastia This booklet tells you about gynaecomastia. It explains what gynaecomastia is, what causes it, how it s diagnosed and what will happen if it needs to be treated or followed up. Benign breast
More informationTESTOFEN. Anabolic & Androgenic Activity GENCOR PACIFIC, INC. Fenugreek Extract standardized for FENUSIDE TM. Copyright 2005 by Gencor Pacific, Inc.
GENCOR PACIFIC, INC. 920E. Orangethorpe Avenue, Suite B, Anaheim, CA. 92801 Ph: 714.870.8723 714.870.8724 efax: 732.875.0306 drjit@gencorpacific.com manu@gencorpacific.com www.gencorpacific.com TESTOFEN
More informationSUMMACARE COMMERCIAL MEDICATION REQUEST GUIDELINES TESTOSTERON. Generic Brand HICL GCN Exception/Other ROUTE MISCELL.
Generic Brand HICL GCN Exception/Other ANDRODERM 01403 ROUTE MISCELL. ANDROGEL AXIRON FORTESTA NATESTO STRIANT TESTIM VOGELXO DEPO- 01400 ROUTE MISCELL. CYPIONATE TESTOSTERON E GCN 38586 DELATESTRYL 01401
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Androgens and Anabolic Steroids Page 1 of 57 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Androgens and Anabolic Steroids Prime Therapeutics will review Prior
More informationTestim 1% PRODUCT MONOGRAPH. (testosterone gel) Androgens. Paladin Labs Inc. 100 Alexis Nihon Blvd., Suite 600 St. Laurent, Quebec H4M 2P2
PRODUCT MONOGRAPH C Testim 1% (testosterone gel) Androgens Paladin Labs Inc. 100 Alexis Nihon Blvd., Suite 600 St. Laurent, Quebec H4M 2P2 Date of Revision: February 3, 2017 Control No: 201331-1 - Table
More informationNebido 1000mg/4ml, solution for injection
Nebido 1000mg/4ml, solution for injection Summary of Product Characteristics Updated 19-Oct-2018 Bayer plc 1. Name of the medicinal product Nebido 1000 mg/4 ml, solution for injection. 2. Qualitative and
More informationInappropriate Testosterone Billings
Inappropriate Testosterone Billings Carla Patrick-Fagan March 30, 2015 Truven Health Analytics Inc. All Rights Reserved. 1 Agenda Proposed in the 2015 analytic plan Steroid prescriptions Code of Federal
More informationIf looking for a book Testosterone: Boost Testosterone Naturally - For - Weight Loss, Muscle Building, Libido & Erectile Dysfunction (Testosterone
Testosterone: Boost Testosterone Naturally - For - Weight Loss, Muscle Building, Libido & Erectile Dysfunction (Testosterone Enanthate, Testosterone Replacement... Pressure, Tongkat Ali, Increase Testo)
More informationscr.zacks.com 10 S. Riverside Plaza, Suite 1600, Chicago, IL (LPCN - NASDAQ) INITIATION ZACKS ESTIMATES
Small-Cap Research August 18, 2014 Jason Napodano, CFA David Bautz, PhD 312-265-9421 / jnapodano@zacks.com scr.zacks.com 10 S. Riverside Plaza, Suite 1600, Chicago, IL 60606 Lipocine, Inc. (LPCN - NASDAQ)
More informationTestosterone as a Therapeutic Tool
330 Medicine Update 56 Testosterone as a Therapeutic Tool SV MADHU INTRODUCTION Testosterone preparations have been available for many years and have been used by physicians primarily to treat sexual problems.
More informationTestosterone Replacement Therapy
30 Bond Street, Toronto ON, M5B 1W8 www.odprn.ca info@odprn.ca Testosterone Replacement Therapy Environmental Scan and Local/Historical Context December 1, 2014 2 Executive Summary Part A: Pharmacy Benefit
More informationAndriol Testocaps. NAME OF THE MEDICINE: Testosterone undecanoate DESCRIPTION PRODUCT INFORMATION
PRODUCT INFORMATION Andriol Testocaps NAME OF THE MEDICINE: Testosterone undecanoate Testosterone undecanoate, the active ingredient of Andriol Testocaps, is a white to creamy-white crystalline powder.
More informationw w w. o p t i m a l h e a l t h m d. c o m Optimal Health & Rejuvenation Center, LLC 2007
Optimize your life. LONGEVITY GUIDE TO 2 0 0 7 w w w. o p t i m a l h e a l t h m d. c o m Optimize your life. INTRODUCTION..................................I DO YOU NEED THERAPY?.........................1
More informationFemale testosterone level chart
Female testosterone level chart The Borg System is 100 % Female testosterone level chart Mar 23, 2015. Male, Female. Age: T Level (ng/dl):, Age: T Level (ng/dl):. 0-5 mo. 75-400, 0-5 mo. 20-80. 6 mos.-9
More informationLong-term experience with testosterone replacement through scrotal skin
CHAPTER 13 1 Long-term experience with testosterone replacement through scrotal skin Linda E. Atkinson, Yu-Lin Chang, and Peter J. Snyder Contents 13.1 13.1.1 13.1.2 13.2 13.2.1 13.2.2 13.2.2.1 13.2.2.2
More informationRunning head: Extremely low testosterone due to RED-S
AACE Clinical Case Reports Rapid Electronic Articles in Press Rapid Electronic Articles in Press are preprinted manuscripts that have been reviewed and accepted for publication, but have yet to be edited,
More informationDr Tarza Jamal Pharmacology Lecture 2
Contraceptives and androgen hormone Contraceptives: Currently, interference with ovulation is the most common pharmacologic intervention for preventing pregnancy. Major classes of contraceptives 1. Combination
More informationTreatment of androgen deficiency in the aging male
Treatment of androgen deficiency in the aging male The Practice Committee of the American Society for Reproductive Medicine Birmingham, Alabama Although guidelines for androgen replacement therapy for
More informationNatural testosterone enhancement pills
Natural testosterone enhancement pills May 6, 2015. WebMD discusses whether it's possible to boost low testosterone levels naturally. May 29, 2018. Do testosterone supplements actually work in boosting
More informationCigna Drug and Biologic Coverage Policy
Cigna Drug and Biologic Coverage Policy Subject Implantable Hormone Pellets Table of Contents Coverage Policy... 1 General Background... 3 Coding/Billing Information... 5 References... 6 Effective Date...
More informationWhat is the difference with Whey, Casein, BCAA's, Glutamine, NO products?
Charles Glass - Mr. World / IFBB PRO Senior Executive Vice President Personal Trainers Association (PROPTA) PROPTA Master Trainer about Recov Bipeptides This is the best protein supplement I ever tried
More informationFormally known as anabolic steroids or anabolic-androgenic steroids, but they are sometimes called 'roids', 'gear' or 'juice'.
Steroids What are steroids? Steroids are drugs that help the growth and repair of muscle tissue. They are synthetic hormones that imitate male sex hormones, specifically testosterone. Steroids can increase
More informationBuy The Complete Version of This Book at Booklocker.com:
Maintain youthful libido, sexual function, cardiovascular, bone, muscle, overall health. The Gentleman's Guide to the Fountain of Youth Buy The Complete Version of This Book at Booklocker.com: http://www.booklocker.com/p/books/2056.html?s=pdf
More informationPRODUCT INFORMATION REANDRON 1000
PRODUCT INFORMATION REANDRON 1000 NAME OF THE MEDICINE Reandron 1000 is a hormonal preparation that contains 1000 mg testosterone undecanoate. The chemical name for testosterone undecanoate is (17β)-17-[(1-Oxoundecyl)oxy]-androst-4-
More informationLIFETIME FITNESS HEALTHY NUTRITION. UNIT 2 Lesson 14 FLEXIBILITY LEAN BODY COMPOSITION
LIFETIME FITNESS HEALTHY NUTRITION MUSCULAR STRENGTH AEROBIC ENDURANCE UNIT 2 Lesson 14 FLEXIBILITY LEAN BODY COMPOSITION MUSCULAR ENDURANCE Created by Derek G. Becher B.P.E., B. Ed., AFLCA Resistance
More informationTESTIM (testosterone gel) for topical use, CIII Initial U.S. Approval: 1953
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TESTIM safely and effectively. See full prescribing information for TESTIM. TESTIM (testosterone
More informationSafety and Tolerability of the Dual 5a-Reductase Inhibitor Dutasteride in thetreatment of Benign Prostatic Hyperplasia
European Urology European Urology 44 (2003) 82 88 Safety and Tolerability of the Dual 5a-Reductase Inhibitor in thetreatment of Benign Prostatic Hyperplasia Gerald L. Andriole a,*,1, Roger Kirby b a Division
More informationUnderstanding combined oral contraception
Understanding combined oral contraception Paula Briggs, FFSRH Consultant in Community Sexual and Reproductive Health Southport and Ormskirk NHS Hospital Trust May Logan Centre, Bootle, L20 5DQ paulaeb@aol.com
More informationAN INTRODUCTION TO EQUINE METABOLIC SYNDROME AND EQUINE CUSHING S DISEASE. Allison Doherty Port Perry Veterinary Services
AN INTRODUCTION TO EQUINE METABOLIC SYNDROME AND EQUINE CUSHING S DISEASE Allison Doherty Port Perry Veterinary Services Me with my redheaded mares and their friend Equine Metabolic Syndrome Equine Metabolic
More informationGrowth Hormone & Somatotropin are an Ergogenic Aid
Growth Hormone & Somatotropin are an Ergogenic Aid BPK 312 MARCH 28 2017 MICHAEL MORKOS PAUL SOURIAL DEL INGVALDSON Table of Contents 1. Hypothesis 2. Clinical Use 3. Mechanism of Action 4. Growth hormone
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Androgens and Anabolic Steroids Page 1 of 53 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Androgens and Anabolic Steroids Prime Therapeutics will review Prior
More informationPolicy. covered: bilateral. alcohol or. Approve. 3. Palliative enanthate injection in. women for. 6 months if. can also sponsive tumor.
Injectablee Testosterone Products Prior Authorization Policy Number: 5.01.597 Origination: 07/2014 Last Review: 07/2014 Next Review: 07/2015 Policy BCBSKC will provide coverage for injectable testosterone
More informationGrowth Hormone s Impact as a Safe Ergogenic Aid to Increase Body Size
Growth Hormone s Impact as a Safe Ergogenic Aid to Increase Body Size Point Argument: Growth Hormone is a Safe Ergogenic Aid to Increase Body Size Monica Chauhan Carissa Eastwood Emily Lefler Mar. 28,
More informationVersion 4, 02/2016 SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET. common-spc Pg. 1
Version 4, 02/2016 SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET 1 common-spc Pg. 1 SUMMARY OF PRODUCT CHARACTERISTICS 2 common-spc Pg. 2 1. NAME OF THE MEDICINAL PRODUCT Testavan 20
More informationAndroGel. (testosterone gel) 1% H 3 C
1 AndroGel (testosterone gel) 1% 500122/500127 Rev Dec 2004 DESCRIPTION AndroGel (testosterone gel) is a clear, colorless hydroalcoholic gel containing 1% testosterone. AndroGel provides continuous transdermal
More informationDUPROST Capsules (Dutasteride)
Published on: 10 Jul 2014 DUPROST Capsules (Dutasteride) Composition Each soft gelatin capsule contains: Dutasteride... 0.5 mg Dosage Form Capsule Pharmacology Pharmacodynamics Mechanism of Action Dutasteride
More information